To approve a drug for a specific indication, the drug must be studied for that indication.
The manufacturer of terbutaline
would then present the data from the clinical studies to the fda
for approval. The fda would then review the data and make a decision to approve or not to approve the drug for that indication. These steps have not occurred, so the drug is not approved.